Dr. Ronald Mitsuyasu, MD
Claim this profileUCLA CARE Center
Studies Squamous Intraepithelial Lesion
Studies Cervical Intraepithelial Lesions
7 reported clinical trials
14 drugs studied
Area of expertise
1Squamous Intraepithelial Lesion
HIV-1 positive
HPV-16 positive
HPV-18 positive
2Cervical Intraepithelial Lesions
HIV-1 positive
Affiliated Hospitals
Clinical Trials Ronald Mitsuyasu, MD is currently running
VGX-3100 + Electroporation
for High-Grade Anal Lesions in HIV
This trial studies a DNA vaccine called VGX-3100 combined with a technique to help it enter cells, aiming to treat HIV-positive patients with severe anal lesions caused by HPV. The vaccine helps the immune system attack harmful cells, and the technique makes it easier for the vaccine to enter the cells. This combination aims to improve treatment effectiveness for these patients. VGX-3100 is being developed as an alternative to surgery for treating precancerous disease while preserving reproductive health.
Recruiting1 award Phase 2
Ixazomib
for Kaposi Sarcoma
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 217 criteria
More about Ronald Mitsuyasu, MD
Clinical Trial Related8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ronald Mitsuyasu, MD has experience with
- Fluorouracil
- Imiquimod
- Infrared Photocoagulation Therapy
- Thermal Ablation Therapy
- Laser Therapy
- Ixazomib Citrate
Breakdown of trials Ronald Mitsuyasu, MD has run
Squamous Intraepithelial Lesion
Cervical Intraepithelial Lesions
Anal Intraepithelial Neoplasia
HIV/AIDS
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ronald Mitsuyasu, MD specialize in?
Ronald Mitsuyasu, MD focuses on Squamous Intraepithelial Lesion and Cervical Intraepithelial Lesions. In particular, much of their work with Squamous Intraepithelial Lesion has involved HIV-1 positive patients, or patients who are HPV-16 positive.
Is Ronald Mitsuyasu, MD currently recruiting for clinical trials?
Yes, Ronald Mitsuyasu, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Ronald Mitsuyasu, MD has studied deeply?
Yes, Ronald Mitsuyasu, MD has studied treatments such as Fluorouracil, Imiquimod, Infrared Photocoagulation Therapy.
What is the best way to schedule an appointment with Ronald Mitsuyasu, MD?
Apply for one of the trials that Ronald Mitsuyasu, MD is conducting.
What is the office address of Ronald Mitsuyasu, MD?
The office of Ronald Mitsuyasu, MD is located at: UCLA CARE Center, Los Angeles, California 90035 United States. This is the address for their practice at the UCLA CARE Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.